Facilities

GeneDesign opens large-scale production facility in Osaka

23-Apr-2019 By Vassia Barba

The Ajinomoto subsidiary opens a development and production base for oligonucleotide drug substances in Japan.

Alvotech provides Stelara biosimilar supply to Fuji Pharma

17-Apr-2019 By Ben Hargreaves

Fuji Pharma signs agreement to receive an exclusive supply of the ustekinumab biosimilar for the Japanese market, furthering a previous investment agreement.

Catalent’s $1.2bn Paragon deal sign of booming gene therapy market

16-Apr-2019 By Ben Hargreaves & Vassia Barba

Catalent to acquire Paragon and plans “substantial capital investments” to ensure Paragon’s further growth, the latest deal in a busy area.

BIO-Europe Spring

Chinese biotechs not ‘inferior’ but actually ‘leapfrogging’ European counterparts

05-Apr-2019 By Ben Hargreaves

The pace at which the Chinese biotech ecosystem is growing has been missed by Europeans, suggests one executive at BIO-Europe Spring.

Alcami Biologics to meet biopharmaceutical demand

03-Apr-2019 By Maggie Lynch

Alcami debuts Alcami Biologics to provide analytical testing, manufacturing, and packaging to the biopharmaceutical industry.

Novo Nordisk initiates $100m rebuild of facilities for next-gen products

02-Apr-2019 By Ben Hargreaves

The Danish company is investing in the rebuild of its existing facilities and is adding production equipment at its site in Kalundborg.

Yescarta to Europe: Steps learned and production 97% on-spec

01-Apr-2019 By Ben Hargreaves

The difficulties in the manufacture of CAR-T treatments have become increasingly understood as the breakthrough technology has been commercialised, but Kite’s head of medical affairs says its process is nearly flawless.

GE Healthcare and Rockwell work towards biopharma 4.0

29-Mar-2019 By Ben Hargreaves

GE Healthcare partners with Rockwell to improve bioprocessing automation operations, which could reduce review time of batch files and processes by weeks.

MaSTherCell brings ‘large-scale’ advanced therapeutics manufacturing to Europe

28-Mar-2019 By Ben Hargreaves

The CDMO leases a facility in Belgium to manufacture cell and gene therapies at a large-scale, in a move the company claims is a first in Europe.

Investment in UK biotech is up 40% in 2019

27-Mar-2019 By Ben Hargreaves

Investment in UK biotech has climbed dramatically year-on-year in the early part of 2019, according to a BIA report.

Pall agrees to develop New Jersey cell and gene therapy sites

26-Mar-2019 By Ben Hargreaves

Pall Biotech signs an industry participation agreement with the New Jersey Innovation Institute to create two centres designed to develop and manufacture cell and gene therapies.

Ajinomoto continues $100m investment to build out worldwide services

26-Mar-2019 By Ben Hargreaves

Aji Bio-Pharma will add a flexible fill line, packaging and labelling equipment to its worldwide manufacturing network, in an investment worth upwards of $100m.

Single-use technology ‘simplified’ in Pall Biotech partnership

26-Mar-2019 By Maggie Lynch

Pall Corporation collaborates with ARTeSYN Biosolutions for single-use components and fluid management technologies.

Takeda’s plasma manufacturing facility approved by FDA

20-Mar-2019 By Maggie Lynch

US FDA approves Takeda’s acquired plasma manufacturing facility in Georgia, US, for the production of flexbumin 25% solution.

Cellectis to build CAR-T manufacturing sites in US and Europe

14-Mar-2019 By Ben Hargreaves

In a step towards the commercialisation of its ‘off-the-shelf’ CAR-T therapies, Cellectis begins construction of a facility in France and enters lease agreement for US facility.